Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GeneCentric, Janssen collaborate to study genomic drug response biomarkers for NMIBC
GeneCentric and Janssen have collaborated to study genomic drug response biomarkers for non-muscle invasive bladder cancer. (Credit: Emilian Danaila from Pixabay)
GeneCentric and Janssen have collaborated to study genomic drug response biomarkers for non-muscle invasive bladder cancer. (Credit: Emilian Danaila from Pixabay)